Key result
Patients with neuromuscular diseases should receive full immunization according to the national calendar along with additional vaccines, with specific adjustments for immunosuppressive therapies.
Why the study?
There is a lack of information in the current literature describing vaccination principles for patients with spinal muscular atrophy and Duchenne muscular dystrophy.
Emphasizes the priority of full immunization and additional specific vaccines for children with spinal muscular atrophy and Duchenne muscular dystrophy.
Identifies gap in SMA/DMD vaccination guidance; leaves open need for targeted studies and recommendations.
Vaccination is recognized as the most effective, safe, and cost-effective way to prevent infectious diseases and their complications. For patients with chronic diseases, and for patients with neuromuscular diseases in particular, vaccination is the highest priority for the prevention of infectious diseases. In the current literature, there is a lack of information describing the principles of vaccination of patients with spinal muscular atrophy and Duchenne muscular dystrophy. In patients with neuromuscular diseases, full immunization has to be done in accordance with the National calendar and recommendations with the introduction of an additional vaccine against such diseases as: rotavirus infection, pneumococcal infection (using an additional dose of 23-valent vaccine), meningococcal infection, virus human papilloma, respiratory viral infection. syncytial virus and influenza. In this regard, of particular importance is the development of recommendations describing the schemes for the use of vaccines in children suffering from spinal muscular atrophy and Duchenne muscular dystrophy.
No takes yet. Share an insight, caveat, or question.
D. Vlodavets (2023) conducted a review in Neuromuscular diseases (Spinal muscular atrophy, Duchenne muscular dystrophy). Vaccination was evaluated. Patients with neuromuscular diseases should receive full immunization according to the national calendar along with additional vaccines, with specific adjustments for immunosuppressive therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: